OTC Healthcare - Belgium
OTC Healthcare in Belgium : Market Insight
EXECUTIVE SUMMARY
Another good year for OTC Despite a still unfavourable context Almost all sectors benefit from an improvement Some players more dynamic than others in a highly fragmented competitive environment Slightly better fate anticipated KEY TRENDS AND DEVELOPMENTS
Local policy still strongly impacts OTC sales Possible lower pressure regarding switches and distribution Economic development should be more favourable The quest of longevity and health and wellness fuels VDS Is the success of functional food and beverage and some cosmetic & toiletries a threat or an opportunity? Increasingly tough and maybe less fragmented competitive environment APPENDIX
OTC Registration and Classification De-listing or De-reimbursement Advertising Packaging and Labelling Distribution Vitamins & Dietary Supplements Registration and Classification Generics APPENDIX
Consumer Expenditure on Health Goods and Medical Services
Table 1 Consumer Expenditure on Health Goods and Medical Services 2001-2006
MARKET INDICATORS
Table 2 Life Expectancy at Birth 2001-2006
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 5 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 6 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 7 Penetration of Private Label by Sector 2002-2006
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
DEFINITIONS
Sources
Summary 1 Research Sources
Local Company Profiles - Belgium
Arkopharma Belux SA - OTC Healthcare - Belgium
STRATEGIC DIRECTION KEY FACTS
Summary 2 Arkopharma Belux SA: Key Facts
Summary 3 Arkopharma Belux SA: Operational Indicators
COMPANY BACKGROUND & PRODUCTION
Summary 4 Arkopharma Belux SA: Production Statistics 2005
COMPETITIVE POSITIONING
Summary 5 Arkopharma Belux SA: Competitive Position 2006
Biodynamics NV - OTC Healthcare - Belgium
STRATEGIC DIRECTION KEY FACTS
Summary 6 Biodynamics BVBA: Key Facts
COMPANY BACKGROUND & PRODUCTION
Summary 7 Biodynamics BVBA: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 8 Summary Biodynamics BVBA: Competitive Position 2006
Omega Pharma NV - OTC Healthcare - Belgium
STRATEGIC DIRECTION KEY FACTS
Summary 9 Omega Pharma Belgium NV: Key Facts
Summary 10 Omega Pharma Belgium NV: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 11 Omega Pharma Belgium NV: Production Statistics 2004-2005
COMPETITIVE POSITIONING
Summary 12 Summary Omega Pharma Belgium NV: Competitive Position 2006
Patch Pharma SA - OTC Healthcare - Belgium
STRATEGIC DIRECTION KEY FACTS
Summary 13 Patch Pharma NV SA: Key Facts
COMPANY BACKGROUND & PRODUCTION COMPETITIVE POSITIONING Vemedia Pharma NV - OTC Healthcare - Belgium
STRATEGIC DIRECTION KEY FACTS
Summary 14 Vemedia Pharma NV: Key Facts
COMPANY BACKGROUND PRODUCTION
Summary 15 Vemedia Pharma NV: Production Statistics 2005
COMPETITIVE POSITIONING
Summary 16 Summary Vemedia Pharma NV: Competitive Position 2006
Analgesics in Belgium
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 12 Sales of Analgesics by Subsector: Value 2001-2006
Table 13 Sales of Analgesics by Subsector: % Value Growth 2001-2006
Table 14 Herbal vs Standard Topical Analgesics 2001/2006
Table 15 Analgesics Company Shares by Retail Value 2002-2006
Table 16 Analgesics Brand Shares by Retail Value 2003-2006
Table 17 Forecast Sales of Analgesics by Subsector: Value 2006-2011
Table 18 Forecast Sales of Analgesics by Subsector: % Value Growth 2006-2011
